These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10657739)

  • 21. Rate of fall in blood glucose and recurrent hypoglycemia affect glucose dynamics and noradrenergic activation in the ventromedial hypothalamus.
    Barnes MB; Lawson MA; Beverly JL
    Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1815-20. PubMed ID: 21957162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ibotenic acid lesions reduce noradrenergic activation in ventromedial hypothalamus during hypoglycemia.
    Fugo KR; Lawson MA; Lee Beverly J
    Brain Res; 2006 Sep; 1111(1):105-10. PubMed ID: 16905122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in responsiveness to serotonin on rat ventromedial hypothalamic neurons after food deprivation.
    Nishimura F; Nishihara M; Torii K; Takahashi M
    Physiol Behav; 1996 Jul; 60(1):7-12. PubMed ID: 8804635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemodynamic consequences of endogenous hyperinsulinism in obese rats with lesions of the ventromedial hypothalamus].
    Doaré L; Mesangeau D; Adli H; Germack R; Perret G; Valensi P
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1015-8. PubMed ID: 10989748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperinsulinemia in rats with ventromedial hypothalamic lesions: role of hyperphagia.
    King BM; Smith RL; Frohman LA
    Behav Neurosci; 1984 Feb; 98(1):152-5. PubMed ID: 6365114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolbutamide increases hypothalamic serotonin activity in the rat.
    Grunstein HS; Smythe GA; Bradshaw JE; Compton PJ
    Diabetes; 1986 Apr; 35(4):475-80. PubMed ID: 2420666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothalamic hyperinsulinemia and obesity: role of adrenal glucocorticoids.
    King BM; Banta AR; Tharel GN; Bruce BK; Frohman LA
    Am J Physiol; 1983 Aug; 245(2):E194-9. PubMed ID: 6349383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamically-induced insulin release and its potentiation during oral and intravenous glucose loads.
    Steffens AB; Flik G; Kuipers F; Lotter EC; Luiten PG
    Brain Res; 1984 Jun; 301(2):351-61. PubMed ID: 6375811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ventromedial hypothalamus stimulation on glycogenolysis in rat liver using in vivo microdialysis.
    Takahashi A; Ishimaru H; Ikarashi Y; Kishi E; Maruyama Y
    Metabolism; 1997 Aug; 46(8):897-901. PubMed ID: 9258271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation by the hypothalamus of glucagon and insulin secretion in rabbits: studies with electrical and chemical stimulations.
    Shimazu T; Ishikawa K
    Endocrinology; 1981 Feb; 108(2):605-11. PubMed ID: 7004860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noradrenergic and GABAergic systems in the medial hypothalamus are activated during hypoglycemia.
    Beverly JL; De Vries MG; Bouman SD; Arseneau LM
    Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R563-9. PubMed ID: 11208588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The modulatory effect of the hypothalamus on glucagon and insulin secretion in the rat.
    Steffens AB
    Diabetologia; 1981 Mar; 20 Suppl():411-6. PubMed ID: 7014337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of serotonin and norepinephrine in spinal antinociception.
    Zhang ZH; Yang SW; Chen JY; Xie YF; Qiao JT; Dafny N
    Brain Res Bull; 1995; 38(2):167-71. PubMed ID: 7583343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoglycemia-induced noradrenergic activation in the VMH is a result of decreased ambient glucose.
    de Vries MG; Lawson MA; Beverly JL
    Am J Physiol Regul Integr Comp Physiol; 2005 Oct; 289(4):R977-81. PubMed ID: 16183631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of procaine injection into the ventromedial hypothalamic area (VMH) of the rat on serum insulin, glucose and corticosterone and gastric emptying rate.
    Duggan JP; Storlien LH; Kraegen EW; Booth DA
    Physiol Behav; 1988; 43(1):29-33. PubMed ID: 3045846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the mechanism of glucose intolerance and insulin resistance in epidemic hemorrhagic fever].
    Sun ZJ; Huang XH; Tang JH
    Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):103-5, 127. PubMed ID: 2567660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasoconstrictor and vasodilator effects of serotonin in the isolated rabbit kidney.
    Li T; Croce K; Winquist RJ
    J Pharmacol Exp Ther; 1992 Dec; 263(3):928-32. PubMed ID: 1469648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic neurotoxin administration to the area of the suprachiasmatic nuclei induces insulin resistance.
    Luo S; Luo J; Meier AH; Cincotta AH
    Neuroreport; 1997 Nov; 8(16):3495-9. PubMed ID: 9427314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal effects of norepinephrine on acute glucose disposal in humans: a minimal model analysis.
    Marangou AG; Alford FP; Ward G; Liskaser F; Aitken PM; Weber KM; Boston RC; Best JD
    Metabolism; 1988 Sep; 37(9):885-91. PubMed ID: 3047523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic adaptation in VMH obesity: in vivo compensatory response to altered neural input.
    Smith FJ; Campfield LA
    Am J Physiol; 1986 Jul; 251(1 Pt 2):R70-6. PubMed ID: 3524273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.